Globe Newswire (Wed, 6-May 4:05 PM ET)
Sight Sciences to Present at Two Upcoming Investor Conferences
Globe Newswire (Wed, 29-Apr 4:05 PM ET)
Market Chameleon (Thu, 23-Apr 7:09 AM ET)
Sight Sciences Announces the Release of its Sustainability Report
Globe Newswire (Wed, 22-Apr 4:45 PM ET)
Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026
Globe Newswire (Tue, 21-Apr 4:05 PM ET)
Globe Newswire (Wed, 1-Apr 4:05 PM ET)
Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th
Globe Newswire (Mon, 30-Mar 4:05 PM ET)
Globe Newswire (Mon, 30-Mar 7:05 AM ET)
Market Chameleon (Fri, 17-Oct 7:14 AM ET)
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
Sight Sciences trades on the NASDAQ stock market under the symbol SGHT.
As of June 30, 2026, SGHT stock price declined to $5.42 with 112,271 million shares trading.
SGHT has a beta of 2.45, meaning it tends to be more sensitive to market movements. SGHT has a correlation of 0.13 to the broad based SPY ETF.
SGHT has a market cap of $294.87 million. This is considered a Small Cap stock.
Last quarter Sight Sciences reported $20 million in Revenue and -$.24 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.04.
In the last 3 years, SGHT traded as high as $9.31 and as low as $1.04.
The top ETF exchange traded funds that SGHT belongs to (by Net Assets): IWM, VTI, IWO, VXF, SMLF.
SGHT has outperformed the market in the last year with a price return of +26.0% while the SPY ETF gained +22.7%. SGHT has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +39.7% and +8.0%, respectively, while the SPY returned +18.1% and -0.8%, respectively.
SGHT support price is $5.55 and resistance is $6.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SGHT shares will trade within this expected range on the day.
